Why diagnosis codes alone fall short for long COVID surveillance
When our client, a global pharmaceutical company, set out to better understand long COVID pathways,...
Topic
Case Studies
HPV vaccination trends from 2016 to 2025: Progress and missed opportunities
by: Alexandra Miller, MPH Human papillomavirus (HPV) is one of the most common sexually...
Trusted by the NSF: How HealthVerity set the standard for secure data linkage
When two federal agencies, the National Center for Science and Engineering Statistics (NCSES) and...
Real-world evidence on cenobamate monotherapy in epilepsy
Why real-world data matters in epilepsy research Epilepsy affects millions of adults in the United...
Disparities in OUD treatment: Buprenorphine vs. naltrexone
Understanding disparities in opioid use disorder (OUD) treatment Pharmaceutical companies committed...
Gilead uses HealthVerity data to find liver-protective treatment
Antiretroviral therapy (ART) has transformed outcomes for people living with HIV, especially those...
Who's missing out? The truth behind food allergy treatment approvals
Mapping food allergy care with omalizumab and real-world data IgE-mediated food allergies (FAs)...
J&J's real-world bladder cancer study started in HealthVerity Marketplace
High-risk NMIBC: Disease overview and treatment approach Johnson & Johnson quickly identified and...
How government agencies use HealthVerity for public health and AI-powered research
Government health agencies are increasingly turning to real-world data (RWD) for public health...
HealthVerity real-world data supports CDC study on HIV PrEP surveillance
A new peer-reviewed study from the Centers for Disease Control and Prevention (CDC) highlights the...